2 months Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Raymond James & Associates MarketBeat
Raymond James & Associates raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm ow…
Nasdaq 100 · Pharmaceuticals · Regeneron Pharma (REGN)
X